Target intelligence / Profile preview

Spike receptor-binding domain, SARS-CoV-2 (RBD (spike RBD or S RBD))

Target
RBD (spike RBD or S RBD)
Molecular classification
Viral protein domain, Receptor binding domain, Glycoprotein
01

Overview

The spike receptor-binding domain (RBD) is a critical structural domain within the SARS-CoV-2 spike glycoprotein that mediates initial viral attachment and entry into host cells[2][4]. Located within the S1 subunit of the trimeric spike protein, the RBD specifically recognizes and binds to the human angiotensin-converting enzyme 2 (ACE2) receptor on target cell surfaces[1][3][4]. Upon ACE2 binding, the RBD undergoes dynamic conformational changes characterized by transitions between "up" (receptor-accessible) and "down" (receptor-inaccessible) conformations, as well as localized structural rearrangements involving secondary structures such as α-helices, β-strands, and κ-helices[1][5][6]. The RBD has emerged as a primary therapeutic target for COVID-19 due to its essential role in viral tropism and its high immunogenicity[8]. Structural studies have revealed that the RBD's binding interface with ACE2 is stabilized by hydrogen bonds, salt bridges, and van der Waals interactions, with conformational changes at a distant hinge region facilitating viral membrane fusion[1]. The RBD is particularly attractive for vaccine development because it is more structurally homogeneous and yields higher expression levels than full-length spike ectodomain[8]. Neutralizing antibodies targeting the RBD can effectively block viral entry, and structure-based drug design efforts have identified potential inhibitors targeting the RBD and nearby polybasic cleavage sites[1][3]. These characteristics make the RBD a high-priority target for therapeutic intervention and vaccine development strategies against SARS-CoV-2 and related coronaviruses[1][2].

Other names
Spike protein receptor-binding domainS protein RBDSARS-CoV-2 RBDRBD domain of spike glycoprotein
02

Mechanism of action

ACE2 receptor antagonism (blocking viral attachment); Neutralizing antibody binding; Conformational change inhibition (preventing receptor-induced structural transitions); Polybasic cleavage site targeting (indirect mechanism)

03

Biological functions

Receptor binding (ACE2 binding)Viral attachment to host cellsInitiation of membrane fusionViral entry into host cells
04

Disease associations

Infection (COVID-19)
05

Safety considerations

Structural flexibility and conformational dynamics suggest targeting strategies must account for multiple conformational states
06

Interacting drugs

Vaccines

2 more in the full profile.

07

Biomarkers

RBD-specific antibodies (for vaccine response assessment and immunity monitoring)RBD structural conformation (up vs. down states for receptor accessibility)

Beyond the preview

Go deeper on Spike receptor-binding domain, SARS-CoV-2 (RBD (spike RBD or S RBD)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spike receptor-binding domain, SARS-CoV-2 (RBD (spike RBD or S RBD)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call